Pharmaceutical Information Network
DrugPR DrugPR
Pharmaceutical and Biotechnology
Press Releases

Alphabetical Listing by Brand Name or Generic Name

Add Your Press Release to DrugPR * Disclaimer


Alphabetical Listing by Brand Name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A...

Aceon (perindopril erbumine)

* SOLVAY PHARMACEUTICALS, INC. INTRODUCES ACEON TABLETS TO U.S. MARKET - 6 Oct 99

Adriamycin (doxorubicin injection)

* Taxotere Plus Doxorubicin Shows Significant Activity in Metastatic Breast Cancer - 15 Dec 1998
* WOMEN WITH METASTATIC BREAST CANCER RESPOND TO TAXOTERE® ... - 15 Dec 1998

Arava (leflunomide)

* Arava® (Leflunomide) Recommended For Approval By FDA Advisory Committee ... - 7 Aug 1998
* Arava (Leflunomide) Approved For Adult Rheumatoid Arthritis - 11 Sep 1998
* FDA Approves Arava (Leflunomide) - 11 Sep 1998

B...

Baycol (cerivastatin)

* New Cholesterol-Lowering Agent From Bayer Cleared By FDA - 30 Jun 1997

C...

Campto/Camptosar (irinotecan)

* FDA APPROVAL OF COLORECTAL CANCER TREATMENT... - 23 Oct 1998

D...

Diovan (valsartan)

* CLINICAL TRIAL: TREATING PATIENTS WITH DIABETES ... - 21 Sep 98
* NEW STUDY SHOWS DIOVAN® (VALSARTAN) REDUCES LEFT VENTRICULAR HYPERTROPHY - 10 November 98

E...

Enbrel (etanercept)

* Enbrel (Etanercept) Recommended for Approval For Rheumatoid Arthritis - 16 Sep 98

Evista (raloxifene)

* Evista (Raloxifene) Osteoporosis Trials Show Reductions in Breast Cancer Incidence - 18 May 98
* Statement Regarding Raloxifene Data ... - 17 May 98

H...

Herceptin

* Herceptin, First Monoclonal Antibody to Slow Metastatic Breast Cancer - 17 May 98
* Biotechnology Breakthrough In Breast Cancer Wins FDA Approval - 25 Sep 98

N...

Nolvadex (tamoxifen)

* Tamoxifen (Nolvadex) Breast Cancer Prevention Trial Results Published - 14 Sep 98

R...

Refludan (lepirudin [rDNA])

* Refludan(tm) Approved for Use in the United States - 9 Mar 98
* OASIS Studies Show Lepirudin Cuts Heart Attacks and Deaths by One Quarter- 25 Aug 98

Relenza (zanamivir)

* STUDY SUGGESTS NEW DRUG PREVENTS SPREAD OF FLU BETWEEN FAMILY MEMBERS - 26 Sep 99

Requip (ropinirole)

* NEW STUDIES PROVIDE FURTHER EVIDENCE THAT REQUIP IS AN EFFECTIVE ... - 13 Jan 98

Rezulin (troglitazone)

* Warner-Lambert Pleased By FDA Advisory Committee Recommendation ... - 26 Mar 99
* Warner-Lambert voluntarily withdraws REZULIN - 21 Mar 2000

S...

Singulair (montelukast)

* STUDY SUGGESTS NEW DRUG PREVENTS SPREAD OF FLU BETWEEN FAMILY MEMBERS - 8 Sep 99

T...

Tasmar (tolcapone)

* Tasmar Label Change in the US - Suspension in the European Union - 17 Nov 98

Taxol (paclitaxel)

* NEW TAXOL REGIMEN SIGNIFICANTLY INCREASES A WOMAN'S CHANCES ... - 18 May 98

Taxotere (docetaxel)

* Taxotere Plus Doxorubicin Shows Significant Activity in Metastatic Breast Cancer - 15 Dec 98
* WOMEN WITH METASTATIC BREAST CANCER RESPOND TO TAXOTERE® ... - 15 Dec 98

Temodar (temozolomide)

* FDA APPROVES NEW DRUG FOR BRAIN CANCER - 11 August 99

V...

Viagra (sildenafil)

* FDA APPROVES IMPOTENCE PILL, VIAGRA - 27 Mar 98
* Viagra Meets 'Ultimate Goal' For Erectile Dysfunction Treatment - 13 May 98
* Viagra (Sildenafil) Appropriate Use Guidelines Reiterated - 21 May 98

X...

Xeloda (capecitabine)

* Xeloda (Capecitabine) Approved For Metastatic Breast Cancer - 30 Apr 98


Alphabetical Listing by Generic Name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C...

capecitabine (Xeloda)

* Xeloda (Capecitabine) Approved For Metastatic Breast Cancer - 30 Apr 98

D...

docetaxel (Taxotere)

* Taxotere Plus Doxorubicin Shows Significant Activity in Metastatic Breast Cancer - 15 Dec 98
* WOMEN WITH METASTATIC BREAST CANCER RESPOND TO TAXOTERE® ... - 15 Dec 98

doxorubicin injection (Adriamycin)

* Taxotere Plus Doxorubicin Shows Significant Activity in Metastatic Breast Cancer - 15 Dec 1998
* WOMEN WITH METASTATIC BREAST CANCER RESPOND TO TAXOTERE® ... - 15 Dec 1998

E...

etanercept (Enbrel)

* Enbrel (Etanercept) Recommended for Approval For Rheumatoid Arthritis - 16 Sep 98

I...

irinotecan (Campto/Camptosar)

* FDA APPROVAL OF COLORECTAL CANCER TREATMENT... - 23 Oct 1998

L...

leflunomide (Arava)

* Arava® (Leflunomide) Recommended For Approval By FDA Advisory Committee ... - 7 Aug 1998
* Arava (Leflunomide) Approved For Adult Rheumatoid Arthritis - 11 Sep 1998
* FDA Approves Arava (Leflunomide) - 11 Sep 1998

lepirudin [rDNA] (Refludan)

* Refludan(tm) Approved for Use in the United States - 9 Mar 98
* OASIS Studies Show Lepirudin Cuts Heart Attacks and Deaths by One Quarter- 25 Aug 98

M...

montelukast (Singulair)

* STUDY SUGGESTS NEW DRUG PREVENTS SPREAD OF FLU BETWEEN FAMILY MEMBERS - 8 Sep 99

P...

paclitaxel (Taxol)

* NEW TAXOL REGIMEN SIGNIFICANTLY INCREASES A WOMAN'S CHANCES ... - 18 May 98

perindopril erbumine (Aceon)

* SOLVAY PHARMACEUTICALS, INC. INTRODUCES ACEON TABLETS TO U.S. MARKET - 6 Oct 99

R...

raloxifene (Evista)

* Evista (Raloxifene) Osteoporosis Trials Show Reductions in Breast Cancer Incidence - 18 May 98
* Statement Regarding Raloxifene Data ... - 17 May 98

ropinirole (Requip)

* NEW STUDIES PROVIDE FURTHER EVIDENCE THAT REQUIP IS AN EFFECTIVE ... - 13 Jan 98

S...

sildenafil (Viagra)

* FDA APPROVES IMPOTENCE PILL, VIAGRA - 27 Mar 98
* Viagra Meets 'Ultimate Goal' For Erectile Dysfunction Treatment - 13 May 98
* Viagra (Sildenafil) Appropriate Use Guidelines Reiterated - 21 May 98

T ...

tamoxifen (Nolvadex)

* Tamoxifen (Nolvadex) Breast Cancer Prevention Trial Results Published - 14 Sep 98

temozolomide (Temodar)

* FDA APPROVES NEW DRUG FOR BRAIN CANCER - 11 August 99

tolcapone (Tasmar)

* Tasmar Label Change in the US - Suspension in the European Union - 17 Nov 98

troglitazone (Rezulin)

* Warner-Lambert Pleased By FDA Advisory Committee Recommendation ... - 26 Mar 99
* Warner-Lambert voluntarily withdraws REZULIN - 21 Mar 2000

V...

valsartan (Diovan)

* CLINICAL TRIAL: TREATING PATIENTS WITH DIABETES ... - 21 Sep 98
* NEW STUDY SHOWS DIOVAN® (VALSARTAN) REDUCES LEFT VENTRICULAR HYPERTROPHY - 10 November 98

Z...

zanamivir (Relenza)

* STUDY SUGGESTS NEW DRUG PREVENTS SPREAD OF FLU BETWEEN FAMILY MEMBERS - 26 Sep 99

Add Your Press Release to DrugPR

PharmInfoNet would like to place your product press releases in DrugPR.

There is no fee for this service

Send press releases via email to John Mack jmack@mediconsult.com or call 215-504-4164.

We accept press releases in electronic format only. Our decision regarding acceptable content for DrugPR is final.


Disclaimer

PharmInfoNet and Mediconsult.com Limited are not responsible for the accuracy of information or promotional claims made in any press release. We encourage readers with questions to contact the person listed in each press release.
* Drug InfoBase HomePage

: PharmInfoNet HomePage

© 1999 Mediconsult.com Limited. All rights reserved. As seen on PharmInfoNet ()